Kempen, J. H., Altaweel, M. M., Drye, L. T., Holbrook, J. T., Jabs, D. A., Sugar, E. A., & Thorne, J. E. (2015). Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Intraocular Implant for Intermediate, Posterior or Panuveitis: 54 month results of The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. Ophthalmology.

Kempen, John H., Michael M. Altaweel, Lea T. Drye, Janet T. Holbrook, Douglas A. Jabs, Elizabeth A. Sugar, i Jennifer E. Thorne. "Quality of Life and Risks Associated With Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Intraocular Implant for Intermediate, Posterior or Panuveitis: 54 Month Results of The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study." Ophthalmology 2015.

Kempen, John H., et al. "Quality of Life and Risks Associated With Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Intraocular Implant for Intermediate, Posterior or Panuveitis: 54 Month Results of The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study." Ophthalmology 2015.